Literature DB >> 1343638

[High incidence of left ventricular thrombosis and systemic embolism in patients with left ventricular assist system].

S Beppu1, N Tanaka, H Noda, T Nakatani, S Nakatani, K Kumon, H Takano, K Miyatake.   

Abstract

The purpose of this study was to determine the incidence of left ventricular (LV) thrombosis and systemic embolism in 14 patients with LV assist systems. Echocardiography was used to detect LV wall motion abnormalities, intracavitary smoke-like echoes and thrombosis, and the effect of anticoagulant therapy was serially examined. During full assist of the circulation, the aortic valve did not open in any patient. Smoke-like echoes were observed in 9 patients (64%) and thrombi in 8 (57%). The thrombus developed within the first 3 assist days. Systemic anticoagulant therapy decreased the thrombus size in only 3 patients, but there was a possibility of intracranial or mediastinal bleeding in other 3 patients. Systemic embolism was noted in 7 of 11 autopsy patients (64%). The characteristic finding was that there were multiple embolized organs, such as the brain, kidneys, spleen and liver, in all patients. Development of a thrombus is a serious complication in all patients with LV assist systems. However, the problem does not lie in the assist system but in the left ventricle of the patient's own heart. It is also noteworthy that systemic anticoagulation is not effective for an LV thrombus. A new method of assisting the failing heart, or a new anticoagulant delivery technique for the LV cavity to prevent LV thrombus development is needed.

Entities:  

Mesh:

Year:  1992        PMID: 1343638

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  1 in total

1.  Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.

Authors:  Farhan Majeed; Willem J Kop; Robert S Poston; Seeta Kallam; Mandeep R Mehra
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.